The Global Idiopathic Pulmonary Fibrosis Treatment Market size was valued at USD 2.00 billion in 2020 and is estimated to expand at a CAGR of 12% over the forecast period 2022-2028. Idiopathic pulmonary fibrosis (IPF) refers to progressive and irreversible fibrosing interstitial pneumonia that directly affects the function of the lungs. It is characterized by […]
